Literature DB >> 33893332

Nine residues in HLA-DQ molecules determine with susceptibility and resistance to type 1 diabetes among young children in Sweden.

George K Papadopoulos1, Lue Ping Zhao2, Antonis K Moustakas3, George P Bondinas1, Annelie Carlsson4, Helena Elding Larsson5, Johnny Ludvigsson6, Claude Marcus7, Martina Persson8, Ulf Samuelsson6, Ruihan Wang9, Chul-Woo Pyo9, Daniel E Geraghty9, Åke Lernmark5.   

Abstract

HLA-DQ molecules account over 50% genetic risk of type 1 diabetes (T1D), but little is known about associated residues. Through next generation targeted sequencing technology and deep learning of DQ residue sequences, the aim was to uncover critical residues and their motifs associated with T1D. Our analysis uncovered (αa1, α44, α157, α196) and (β9, β30, β57, β70, β135) on the HLA-DQ molecule. Their motifs captured all known susceptibility and resistant T1D associations. Three motifs, "DCAA-YSARD" (OR = 2.10, p = 1.96*10-20), "DQAA-YYARD" (OR = 3.34, 2.69*10-72) and "DQDA-YYARD" (OR = 3.71, 1.53*10-6) corresponding to DQ2.5 and DQ8.1 (the latter two motifs) associated with susceptibility. Ten motifs were significantly associated with resistance to T1D. Collectively, homozygous DQ risk motifs accounted for 43% of DQ-T1D risk, while homozygous DQ resistant motifs accounted for 25% protection to DQ-T1D risk. Of the identified nine residues five were within or near anchoring pockets of the antigenic peptide (α44, β9, β30, β57 and β70), one was the N-terminal of the alpha chain (αa1), one in the CD4-binding region (β135), one in the putative cognate TCR-induced αβ homodimerization process (α157), and one in the intra-membrane domain of the alpha chain (α196). Finding these critical residues should allow investigations of fundamental properties of host immunity that underlie tolerance to self and organ-specific autoimmunity.

Entities:  

Year:  2021        PMID: 33893332     DOI: 10.1038/s41598-021-86229-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  60 in total

1.  Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity.

Authors:  J Ilonen; M Kiviniemi; J Lempainen; O Simell; J Toppari; R Veijola; M Knip
Journal:  Pediatr Diabetes       Date:  2016-07       Impact factor: 4.866

Review 2.  Genetic risk factors for type 1 diabetes.

Authors:  Flemming Pociot; Åke Lernmark
Journal:  Lancet       Date:  2016-06-04       Impact factor: 79.321

3.  Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States.

Authors:  M J Redondo; L Yu; M Hawa; T Mackenzie; D A Pyke; G S Eisenbarth; R D Leslie
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

4.  HLA genotyping in the international Type 1 Diabetes Genetics Consortium.

Authors:  Josyf C Mychaleckyj; Janelle A Noble; Priscilla V Moonsamy; Joyce A Carlson; Michael D Varney; Jeff Post; Wolfgang Helmberg; June J Pierce; Persia Bonella; Anna Lisa Fear; Eva Lavant; Anthony Louey; Sean Boyle; Julie A Lane; Paul Sali; Samuel Kim; Rebecca Rappner; Dustin T Williams; Letitia H Perdue; David M Reboussin; Brian D Tait; Beena Akolkar; Joan E Hilner; Michael W Steffes; Henry A Erlich
Journal:  Clin Trials       Date:  2010-07-01       Impact factor: 2.486

5.  Analysis of HLA genes in families with autoimmune diabetes and thyroiditis.

Authors:  Lara Levin; Yoshiyuki Ban; Erlinda Concepcion; Terry F Davies; David A Greenberg; Yaron Tomer
Journal:  Hum Immunol       Date:  2004-06       Impact factor: 2.850

6.  A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.

Authors:  Jonathan P Bradfield; Hui-Qi Qu; Kai Wang; Haitao Zhang; Patrick M Sleiman; Cecilia E Kim; Frank D Mentch; Haijun Qiu; Joseph T Glessner; Kelly A Thomas; Edward C Frackelton; Rosetta M Chiavacci; Marcin Imielinski; Dimitri S Monos; Rahul Pandey; Marina Bakay; Struan F A Grant; Constantin Polychronakos; Hakon Hakonarson
Journal:  PLoS Genet       Date:  2011-09-29       Impact factor: 5.917

7.  Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4, and 5 Include Potentially Causal Residues Responsible for the Risk of Childhood Type 1 Diabetes.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Bryan Xu; Matthew Kong; Antonis K Moustakas; George P Bondinas; Annelie Carlsson; Helena Elding-Larsson; Johnny Ludvigsson; Claude Marcus; Martina Persson; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

8.  Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A.

Authors:  J M M Howson; N M Walker; D Clayton; J A Todd
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

9.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.

Authors:  John A Todd; Neil M Walker; Jason D Cooper; Deborah J Smyth; Kate Downes; Vincent Plagnol; Rebecca Bailey; Sergey Nejentsev; Sarah F Field; Felicity Payne; Christopher E Lowe; Jeffrey S Szeszko; Jason P Hafler; Lauren Zeitels; Jennie H M Yang; Adrian Vella; Sarah Nutland; Helen E Stevens; Helen Schuilenburg; Gillian Coleman; Meeta Maisuria; William Meadows; Luc J Smink; Barry Healy; Oliver S Burren; Alex A C Lam; Nigel R Ovington; James Allen; Ellen Adlem; Hin-Tak Leung; Chris Wallace; Joanna M M Howson; Cristian Guja; Constantin Ionescu-Tîrgovişte; Matthew J Simmonds; Joanne M Heward; Stephen C L Gough; David B Dunger; Linda S Wicker; David G Clayton
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

10.  Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children.

Authors:  Lue Ping Zhao; George K Papadopoulos; William W Kwok; Antonis K Moustakas; George P Bondinas; Helena Elding Larsson; Johnny Ludvigsson; Claude Marcus; Ulf Samuelsson; Ruihan Wang; Chul-Woo Pyo; Wyatt C Nelson; Daniel E Geraghty; Åke Lernmark
Journal:  Diabetes       Date:  2020-04-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.